Individual investors have shown tremendous interest in the penny stocks in 2020 as the risk-on mood was seen in the markets since its crashing in March. The buying trend in penny stocks is a global phenomenon.

On the downside, a breach of 11,238 levels would open the gates for a further correction towards the zone of 11,157-11,128. This zone is the next important support zone as this a confluence of 20-DMA and 50 per cent retracement level of the recent upswing. Stocks in news: Ahluwalia Contracts, Jindal Steel and Power, Bank of India.

Be prepared for a likely flat start for the Indian markets, owing to mixed global cues. At 7:50 am, SGX Nifty was trading down by 8 points at 11,326.50 levels. Over the last couple of trading sessions, the market is in a state of flux and this has resulted into no clear headway.

The consolidated net sales reported in Q1FY21 came in at Rs 818.16 crore, which declined by 65.65 per cent YoY from Rs 2,381.92 crore in Q1FY20. 

The consolidated net sales reported in Q1FY21 came in at Rs 12,180.62 crore, which declined by 34.09 per cent YoY from Rs 18,481.56 crore in Q1FY20. 

U GRO capital, a new-age listed fintech platform gained 3.50 per cent on Thursday after declaring its Q1 FY21 results.

Eicher Motors on Thursday said that it has signed definitive agreements for the integration of Volvo Buses India business into VE commercial vehicles (VECV), an Eicher Motors’ arm that covers Eicher's commercial vehicles, components, and engineering design businesses as well as the sales and distribution of Volvo trucks.

The shares of eClerx Services were trading in the green and surged 20 per cent to hit its intraday high on Thursday, a day after the company came out with its June quarter earnings.

The Sensex opened in green and stayed like that for the first couple of hours after which it slipped owing to profit booking. It closed at 38310 levels, down by 59 points or 0.15 per cent whereas Nifty closed at the important support level of 11300 levels, down by eight points or 0.07 per cent.

Aleor Dermaceuticals Limited, a joint venture of Alembic Pharmaceuticals Limited, has received tentative approval from United States Food & Drug Administration (USFDA) for its abbreviated new drug application -Tavaborole Topical Solution.